Please login to the form below

Lemtrada

This page shows the latest Lemtrada news and features for those working in and with pharma, biotech and healthcare.

the disease if they have failed to respond to first-line treatment with Sanofi's Lemtrada (alemtuzumab) or have rapidly evolving severe MS.

Celebrating excellence

The London-based agency picked up The Cello Health Award for Launch Excellence for work on behalf of Genzyme and its multiple sclerosis treatment Lemtrada. ... Lucid also picked up the Cello Health Award for Launch Excellence Award for supporting Genzyme
Lucid behavioural change programmes recognised at PMEA

The London-based agency picked The Cello Health Award for Launch Excellence for work on behalf of Genzyme and its multiple sclerosis treatment Lemtrada. ... Lucid also picked up the Cello Health Award for Launch Excellence Award for supporting Genzyme
Sanofi forges $1.5bn cancer partnership with BioNTech

and Lemtrada (alemtuzumab) and subsidiary Genzyme's rare disease portfolio.
Sanofi plans 18 new product launches by 2020

The remainder of its growth portfolio are Cerdelga (eliglustat) for Gaucher disease - the only approved oral, first-line therapy for the rare genetic disease, Lemtrada (alemtuzumab) for multiple sclerosis and sarilumab,
Sanofi persuades FDA to back its MS drug Lemtrada

well-controlled studies that demonstrate the benefits of Lemtrada outweigh its serious adverse effects". ... Lemtrada demonstrated superior efficacy over Rebif on annualised relapse rates in the two studies which were the basis for approval.”.

More from news
Approximately 8 fully matching, plus 25 partially matching documents found.

Executive changes at Sanofi

such as Aubagio (teriflunomide) and Lemtrada (alemtuzumab). “

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Add my company

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Retaining reader value in plain language summaries of clinical studies: Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?: Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds: A vision of Paris as Europe’s leading hub for life sciences innovation...